Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Pospisilova

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Leukemia|October 8, 2014
Detailed analysis of therapy-driven clonal evolution of TP53 mutations in chronic lymphocytic leukemiaJ Malcikova, K Stano-Kozubik, B Tichy, et al.
Leukemia|July 27, 2017
Low-burden TP53 mutations in chronic phase of myeloproliferative neoplasms: association with age, hydroxyurea administration, disease type and JAK2 mutational statusB Kubesova, S Pavlova, J Malcikova, et al.
Leukemia|February 23, 2018
ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia-update on methodological approaches and results interpretationJ Malcikova, E Tausch, D Rossi, et al.
Nature Protocols|August 5, 2016
High-quality full-length immunoglobulin profiling with unique molecular barcodingM A Turchaninova, A Davydov, O V Britanova, et al.
Leukemia|November 6, 2014
The impact of SF3B1 mutations in CLL on the DNA-damage responseG D Te Raa, I A M Derks, V Navrkalova, et al.
Leukemia|September 24, 2010
TP53 mutation profile in chronic lymphocytic leukemia: evidence for a disease specific profile from a comprehensive analysis of 268 mutationsT Zenz, D Vollmer, M Trbusek, et al.
Leukemia|April 6, 2013
Distinct patterns of novel gene mutations in poor-prognostic stereotyped subsets of chronic lymphocytic leukemia: the case of SF3B1 and subset #2J C Strefford, L-A Sutton, P Baliakas, et al.
Leukemia|June 20, 2014
Recurrent mutations refine prognosis in chronic lymphocytic leukemiaP Baliakas, A Hadzidimitriou, L-A Sutton, et al.
Leukemia|November 29, 2016
EGR2 mutations define a new clinically aggressive subgroup of chronic lymphocytic leukemiaE Young, D Noerenberg, L Mansouri, et al.
Leukemia|December 8, 2015
A complementary role of multiparameter flow cytometry and high-throughput sequencing for minimal residual disease detection in chronic lymphocytic leukemia: an European Research Initiative on CLL studyA C Rawstron, C Fazi, A Agathangelidis, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Leukemia|October 8, 2014
Detailed analysis of therapy-driven clonal evolution of TP53 mutations in chronic lymphocytic leukemiaJ Malcikova, K Stano-Kozubik, B Tichy, et al.
Leukemia|July 27, 2017
Low-burden TP53 mutations in chronic phase of myeloproliferative neoplasms: association with age, hydroxyurea administration, disease type and JAK2 mutational statusB Kubesova, S Pavlova, J Malcikova, et al.
Leukemia|February 23, 2018
ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia-update on methodological approaches and results interpretationJ Malcikova, E Tausch, D Rossi, et al.
Nature Protocols|August 5, 2016
High-quality full-length immunoglobulin profiling with unique molecular barcodingM A Turchaninova, A Davydov, O V Britanova, et al.
Leukemia|November 6, 2014
The impact of SF3B1 mutations in CLL on the DNA-damage responseG D Te Raa, I A M Derks, V Navrkalova, et al.
Leukemia|September 24, 2010
TP53 mutation profile in chronic lymphocytic leukemia: evidence for a disease specific profile from a comprehensive analysis of 268 mutationsT Zenz, D Vollmer, M Trbusek, et al.
Leukemia|April 6, 2013
Distinct patterns of novel gene mutations in poor-prognostic stereotyped subsets of chronic lymphocytic leukemia: the case of SF3B1 and subset #2J C Strefford, L-A Sutton, P Baliakas, et al.
Leukemia|June 20, 2014
Recurrent mutations refine prognosis in chronic lymphocytic leukemiaP Baliakas, A Hadzidimitriou, L-A Sutton, et al.
Leukemia|November 29, 2016
EGR2 mutations define a new clinically aggressive subgroup of chronic lymphocytic leukemiaE Young, D Noerenberg, L Mansouri, et al.
Leukemia|December 8, 2015
A complementary role of multiparameter flow cytometry and high-throughput sequencing for minimal residual disease detection in chronic lymphocytic leukemia: an European Research Initiative on CLL studyA C Rawstron, C Fazi, A Agathangelidis, et al.
Pageof 2